CagriSema Dual Injection Pen Kit — Semaglutide + Cagrilintide Dual Protocol
Next-generation dual-pathway kit pairing selective GLP-1 agonist Semaglutide (4mg) with long-acting amylin/calcitonin receptor agonist Cagrilintide (4mg) in two dedicated pens for independent titration.
Analytical Specifications & HPLC Purity
- Batch ID: SYN-26CS-7721N (RP-HPLC Purity: 99.49%)
- CAS / Formula: 910463-68-2 / 1415456-99-3 | C187H291N45O59 + C194H312N54O59S2 (4113.6 + 4409.0 g/mol)
- Format: 4mg + 4mg Dual Kit | 1 click = 0.0667 mg
- Storage: 2°C – 8°C (Refrigerated) | Half-life: ~7–8 days (Co-synchronized)
Kit Contents
- 1x Pen 1: Semaglutide 4mg Precision Pen (60-Unit Dial)
- 1x Pen 2: Cagrilintide 4mg Precision Pen (60-Unit Dial)
- 16x Ultra-Fine 31G 4mm Siliconized Micro-Needles
- 16x Sterile Prep Swabs & Dual-Pen Collector Case
60-Unit Pen Titration & Click Schedule
| Weeks | Dose | Clicks | Phase |
|---|---|---|---|
| Weeks 1–4 | 0.25 mg Sema + 0.25 mg Cagri | 4 units each pen | Dual-Receptor Co-Initiation |
| Weeks 5–8 | 0.50 mg Sema + 0.50 mg Cagri | 8 units each pen | Synergistic Satiety Step |
| Weeks 9–12 | 1.00 mg Sema + 1.00 mg Cagri | 15 units each pen | Intermediate Dual Protocol |
| Week 13+ | 2.40 mg Sema + 2.40 mg Cagri | 36 units each pen | Target Phase-3 Equivalent |